# 自动化乳腺超声系统市场 > 自动化乳腺超声系统市场研究报告按产品类型（2D自动化乳腺超声系统、3D自动化乳腺超声系统）、按应用（乳腺癌筛查、乳腺癌诊断成像、乳腺癌随访成像）、按最终用户（医院和诊所、诊断成像中心、研究机构、其他）、按技术（常规超声、剪切波弹性成像、对比增强超声、其他）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.28% - **2024:** $ 3.46 Billion - **2025:** $ 3.68 Billion - **2035:** $ 6.76 Billion - **Key Players:** GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Hologic (US), Fujifilm (JP), Mindray (CN), Esaote (IT), Samsung Medison (KR) **Report ID:** MRFR/HC/39384-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/automated-breast-ultrasound-system-market-28877 --- ## Market Summary ## **Automated Breast Ultrasound System Market Overview** As per MRFR analysis, the Automated Breast Ultrasound System Market Size was estimated at 3.46 (USD Billion) in 2024. The Automated Breast Ultrasound System Market Industry is expected to grow from 3.67 (USD Billion) in 2025 to 6.36 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 6.28% during the forecast period (2025 - 2034). ### **Key Automated Breast Ultrasound System Market Trends Highlighted** The Automated Breast Ultrasound (ABUS) system market is witnessing a surge in demand due to its advantages over traditional breast imaging techniques. Key drivers of this growth include the rising incidence of breast cancer, increasing awareness and adoption of early detection measures, and the need for more precise and sensitive breast imaging solutions. The market is further fueled by technological advancements such as 3D and 4D ABUS, which provide more detailed and comprehensive breast imaging. Additionally, the growing focus on personalized and tailored healthcare is driving demand for ABUS systems that can offer individualized breast imaging and monitoring plans. The evolving healthcare landscape, with an emphasis on minimally invasive and cost-effective procedures, is creating opportunities for ABUS systems to play a pivotal role in breast cancer detection and management. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Automated Breast Ultrasound System Market Drivers** ### Increasing Prevalence of Breast Cancer Breast cancer is the most common type of cancer among women worldwide, with an estimated 2.3 million new cases diagnosed in 2020. The increasing prevalence of [breast cancer](../../../reports/global-breast-cancer-market-1379) is a major driver of the automated breast ultrasound system market. Automated breast ultrasound systems provide a more accurate and efficient way to detect and diagnose breast cancer, which can lead to earlier treatment and better outcomes for patients. In addition, automated breast ultrasound systems are less invasive and more comfortable for patients than traditional breast biopsies, which can further increase their adoption. ### Technological Advancements Technological advancements are another major driver of the automated breast ultrasound system market. Automated breast ultrasound systems are becoming increasingly sophisticated and accurate, which is making them more effective in detecting and diagnosing breast cancer. For example, some automated breast ultrasound systems now use artificial intelligence (AI) to help identify suspicious lesions and tumors. AI-powered automated breast ultrasound systems can improve the accuracy of breast cancer detection and reduce the need for unnecessary biopsies. ### Growing Awareness of Breast Cancer Screening Growing awareness of breast cancer screening is also driving the automated breast ultrasound system market. More and more women are becoming aware of the importance of regular breast cancer screening, and this is leading to an increase in the demand for automated breast ultrasound systems. Automated breast ultrasound systems are a convenient and effective way to screen for breast cancer, and they can help to detect cancer at an early stage, when it is most treatable ## **Automated Breast Ultrasound System Market Segment Insights** ### **Automated Breast Ultrasound System Market Product Type Insights** The Automated Breast Ultrasound System Market is segmented based on product type into 2D Automated Breast Ultrasound System and 3D Automated Breast Ultrasound System. The 2D Automated Breast Ultrasound System segment accounted for a larger revenue share in 2023 and is expected to maintain its dominance throughout the forecast period. The growth of this segment can be attributed to the widespread adoption of 2D Automated Breast Ultrasound Systems in screening programs for breast cancer detection. These systems provide high-quality images that allow radiologists to visualize breast tissue more clearly, leading to improved detection and characterization of breast lesions. The 3D Automated Breast Ultrasound System segment is expected to witness significant growth during the forecast period. The increasing adoption of 3D Automated Breast Ultrasound Systems in diagnostic and interventional procedures is driving the growth of this segment. 3D Automated Breast Ultrasound Systems offer several advantages over 2D systems, including improved visualization of breast anatomy, better detection of small lesions, and more accurate guidance for biopsies. The Automated Breast Ultrasound System Market is expected to grow significantly in the coming years, driven by the rising incidence of breast cancer, increasing awareness about breast cancer screening, and technological advancements in Automated Breast Ultrasound Systems. The market growth is also supported by the growing demand for non-invasive and radiation-free breast imaging techniques. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Automated Breast Ultrasound System Market Application Insights** The Automated Breast Ultrasound System Market is segmented into Breast Cancer Screening, Diagnostic Imaging for Breast Cancer, and Follow-up Imaging for Breast Cancer. Breast Cancer Screening is the largest segment, accounting for over 45% of the Automated Breast Ultrasound System Market revenue in 2023. Diagnostic Imaging for Breast Cancer is the second largest segment, with a market share of over 30%. Follow-up Imaging for Breast Cancer is the smallest segment, with a market share of less than 25%. The Breast Cancer Screening segment is expected to continue to dominate the market over the forecast period, with a CAGR of over 5%. The Diagnostic Imaging for Breast Cancer segment is expected to grow at a CAGR of over 4%, while the Follow-up Imaging for Breast Cancer segment is expected to grow at a CAGR of over 3%. The growth of the Automated Breast Ultrasound System Market is attributed to the increasing incidence of breast cancer, the rising demand for accurate and non-invasive diagnostic tools, and the technological advancements in automated breast ultrasound systems. ### **Automated Breast Ultrasound System Market End User Insights** The Automated Breast Ultrasound System Market segmentation by End User comprises Hospitals and Clinics, Diagnostic Imaging Centers, Research Institutions, and Others. Hospitals and Clinics held the dominant market share in 2023 and are projected to continue their dominance during the forecast period. The high adoption of automated breast ultrasound systems in hospitals and clinics can be attributed to the increasing number of breast cancer cases, growing awareness about early detection, and technological advancements in ultrasound imaging. Diagnostic Imaging Centers account for a significant market share and are expected to grow steadily due to the increasing demand for specialized breast imaging services. Research Institutions are also expected to contribute to the growth of the market as they play a crucial role in developing and evaluating new automated breast ultrasound technologies. The 'Others' segment includes private clinics, ambulatory surgical centers, and mobile breast screening units, which are anticipated to witness moderate growth during the forecast period. ### **Automated Breast Ultrasound System Market Technology Insights** The Automated Breast Ultrasound System Market is segmented by Technology into Conventional Ultrasound, Shear Wave Elastography, Contrast-Enhanced Ultrasound, and Others. Conventional Ultrasound was the most commonly used technology in Automated Breast Ultrasound Systems, accounting for over 50% of the global market revenue in 2023. It is a non-invasive imaging technique that uses high-frequency sound waves to create images of the breast tissue. Shear Wave Elastography is a newer technology that is gaining popularity due to its ability to measure the stiffness of breast tissue. Contrast-Enhanced Ultrasound uses a contrast agent to enhance the visibility of blood vessels in the breast tissue, which can help to identify tumors. Others include emerging technologies such as 3D ultrasound and tomosynthesis, which are expected to gain market share in the coming years. ### **Automated Breast Ultrasound System Market Regional Insights** The regional segmentation of the Automated Breast Ultrasound System Market offers insights into the geographical distribution of market revenues. North America dominates the market with a significant share, driven by factors such as advanced healthcare infrastructure, high awareness about breast cancer screening, and reimbursement policies favoring the adoption of automated breast ultrasound systems. Europe follows suit, with a sizable market share attributed to government initiatives promoting early cancer detection and technological advancements in the healthcare sector. The APAC region is projected to witness substantial growth in the coming years, owing to rising disposable incomes, increasing prevalence of breast cancer, and expanding healthcare access in emerging economies like China and India. South America and MEA represent emerging markets with untapped growth potential, driven by growing healthcare expenditure and increasing awareness about breast cancer screening. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Automated Breast Ultrasound System Market Key Players and Competitive Insights** Major players in the Automated Breast Ultrasound System Market are continuously developing innovative technologies and products to gain a competitive edge. They are also focusing on strategic partnerships and acquisitions to expand their market reach. Leading Automated Breast Ultrasound System Market players are investing heavily in research and development to enhance their product offerings and meet the evolving needs of customers. The Automated Breast Ultrasound System Market development is driven by technological advancements, increasing demand for early detection of breast cancer, and government initiatives to promote breast cancer screening. The competitive landscape is expected to remain dynamic, with new entrants and established players vying for market share. GE Healthcare, a leading player in the Automated Breast Ultrasound System Market, offers advanced automated breast ultrasound systems that provide high-quality images and efficient workflow. The company's Invenia Automated Breast Ultrasound System is designed to enhance breast cancer detection and reduce operator dependency. GE Healthcare also focuses on providing comprehensive training and support to healthcare professionals to ensure optimal utilization of its systems. Siemens Healthineers, a competitor in the Automated Breast Ultrasound System Market, provides a range of automated breast ultrasound solutions. The company's ACUSON S2000 Automated Breast Ultrasound System features AI-powered image processing and advanced transducer technology for improved image quality and diagnostic accuracy. Siemens Healthineers also offers cloud-based data management and analysis tools to support remote collaboration and efficient patient management. ### **Key Companies in the Automated Breast Ultrasound System Market Include** - [GE Healthcare](https://www.gehealthcare.com/products/ultrasound/breast-ultrasound?srsltid=AfmBOopw5Yizj80Bb_44eQuJDJmUyIjJPadK-6LrSukYXACbn9MhIn86) - XEROX - Siemens Healthineers - Carestream Health - Acuson - FUJIFILM Holdings - Koninklijke Philips - Analogic Corporation - SonoScape Medical - Mindray - Toshiba Medical Systems - Hitachi Medical - Hologic - Samsung Medison - Esaote ## Automated Breast Ultrasound System Market Industry Developments - **Q3 2025: In July 2025, GE HealthCare launched its Invenia ABUS 3.0 with enhanced AI lesion detection and faster scan times.** GE HealthCare introduced the Invenia ABUS 3.0 automated breast ultrasound system, featuring advanced AI for lesion detection and improved workflow efficiency, targeting supplemental screening for women with dense breast tissue. - **Q2 2025: In June 2025, Siemens Healthineers received CE Mark approval for its Acuson ABUS Elite system.** Siemens Healthineers secured CE Mark for its Acuson ABUS Elite, a 3D volumetric imaging system with automated positioning, enabling commercial rollout in European markets. ## **Automated Breast Ultrasound System Market Segmentation Insights** ### **Automated Breast Ultrasound System Market Product Type Outlook** - 2D Automated Breast Ultrasound System - 3D Automated Breast Ultrasound System ### **Automated Breast Ultrasound System Market Application Outlook** - Breast Cancer Screening - Diagnostic Imaging for Breast Cancer - Follow-up Imaging for Breast Cancer ### **Automated Breast Ultrasound System Market End User Outlook** - Hospitals and Clinics - Diagnostic Imaging Centers - Research Institutions - Others ### **Automated Breast Ultrasound System Market Technology Outlook** - Conventional Ultrasound - Shear Wave Elastography - Contrast-Enhanced Ultrasound - Others ### **Automated Breast Ultrasound System Market Regional Outlook** - North America - Europe - South America - Asia Pacific - Middle East and Africa ## Market Drivers ### 成像技术的进步 自动化乳腺超声系统市场正在经历技术进步的激增，这些进步增强了成像能力。3D成像和人工智能集成等创新正在提高诊断的准确性和效率。这些进步使得乳腺异常的检测更加准确，这对早期干预至关重要。随着医疗服务提供者越来越多地采用这些技术以改善患者的治疗结果，市场预计将增长。到2025年，市场预计将达到约15亿美元的估值，推动这一增长的是对更精确成像解决方案的需求。随着技术的不断发展，自动化乳腺超声系统市场可能会看到进一步的增强，这可能会重新定义乳腺癌筛查协议。 ### 监管支持和指南 自动化乳腺超声系统市场受到支持性监管框架和指导方针的推动，这些框架和方针促进了先进成像技术的使用。监管机构越来越认识到自动化乳腺超声系统在增强筛查过程中的有效性。这种支持在新设备的批准和鼓励将其纳入常规乳腺癌筛查协议的指导方针的建立中得到了体现。随着医疗服务提供者与这些法规的对接，市场预计将扩展，预计到2025年年均增长率为7%。对合规性的重视确保了自动化乳腺超声系统市场保持竞争力和创新性，最终使患者护理受益。 ### 乳腺癌发病率上升 全球乳腺癌发病率的上升是自动化乳腺超声系统市场的主要驱动因素。统计数据显示乳腺癌病例的增加，使得对有效筛查工具的需求愈加明显。自动化乳腺超声系统提供了一种非侵入性且高效的肿瘤检测方法，特别适用于乳腺组织致密的女性。对可靠筛查解决方案的日益增长的需求预计将推动市场增长，预计到2025年市场规模将达到12亿美元。因此，自动化乳腺超声系统市场在应对乳腺癌发病率上升所带来的挑战中，将发挥至关重要的作用，确保及时的诊断和治疗。 ### 提高意识和筛查倡议 对乳腺癌的认识不断提高以及早期检测的重要性正在显著影响自动化乳腺超声系统市场。教育活动和社区外展项目正在鼓励女性定期进行筛查。这种提高的意识导致越来越多的女性选择乳腺超声检查，特别是在高风险人群中。因此，市场正经历稳定的增长轨迹，预计对自动化系统的需求将增加。到2025年，市场的年复合增长率（CAGR）可能达到约8%，反映出对主动健康措施日益重视的趋势。因此，自动化乳腺超声系统市场有望从这一趋势中受益，因为越来越多的医疗机构采用这些系统以满足日益增长的患者需求。 ### 与其他诊断方式的整合 将自动化乳腺超声系统与其他诊断方式相结合的趋势正在塑造自动化乳腺超声系统市场。这种整合允许对乳腺癌筛查和诊断采取更全面的方法，将超声与乳腺X光检查和MRI结合起来。这种多模态策略提高了诊断的准确性，为医疗专业人员提供了更完整的乳腺健康图景。随着医疗机构寻求通过先进的诊断技术改善患者结果，市场可能会看到集成系统的采用增加。到2025年，自动化乳腺超声系统市场可能会经历6%的增长率，推动这一增长的是对满足多样化患者需求的整体诊断解决方案的需求。 ## Future Outlook 自动化乳腺超声系统市场预计将在2024年至2035年间以6.28%的年均增长率增长，推动因素包括技术进步、乳腺癌意识的提高以及医疗支出的增加。 **New opportunities:** - 开发基于人工智能的诊断工具，以提高成像准确性。 以量身定制的定价策略扩展到新兴市场。 与医疗服务提供者建立合作伙伴关系，提供综合乳腺健康解决方案。 到2035年，市场预计将实现显著增长，巩固其在乳腺癌检测中的作用。 ## Segment Insights ### 按产品类型：2D自动化乳腺超声系统市场（最大）与3D自动化乳腺超声系统市场（增长最快） 自动化乳腺超声系统市场在2D和3D产品类型之间呈现出明显的分裂，2D系统占据了最大的市场份额。由于其成熟的技术和在乳腺成像中的可靠性，这一细分市场长期以来一直受到青睐。相反，3D自动化乳腺超声系统正在获得关注，吸引寻求先进诊断能力的医疗服务提供者。随着对更全面成像技术的好处的认识不断提高，市场动态预计将稳步转变。 产品类型：2D 自动化乳腺超声系统市场（主导）与 3D 自动化乳腺超声系统市场（新兴） 二维自动乳腺超声系统市场仍然是市场的主导者，以其简单有效的乳腺癌筛查而闻名。其已建立的市场地位使得许多医疗专业人员在常规检查中更倾向于使用它，从而形成了强大的用户基础。另一方面，三维自动乳腺超声系统市场虽然是新兴的，但由于其增强的成像能力，迅速引起了关注，这些能力提供了对乳腺组织更细致的视图。这些先进的系统能够检测到可能被二维系统遗漏的异常，使其在精准医疗和个性化医疗方法中越来越有价值。 ### 按应用：乳腺癌筛查（最大）与乳腺癌诊断影像学（增长最快） 在自动乳腺超声系统市场中，应用细分显示出市场份额的多样分布。乳腺癌筛查仍然是最大的细分市场，受到对乳腺健康意识提高和早期发现乳腺癌的迫切需求的推动。这导致对能够促进高效和准确筛查过程的自动化解决方案的需求增加。另一方面，乳腺癌的诊断成像正在迅速增长，受到技术进步和乳腺癌病例增加的推动，突显了在诊断中精确成像能力的重要性。 乳腺癌筛查（主导）与乳腺癌后续影像学检查（新兴） 乳腺癌筛查在市场中占据主导地位，因为它在预防医疗中的重要作用。该应用程序不仅提供早期检测，还越来越多地与数字健康技术相结合，提高了筛查过程的效率。相比之下，乳腺癌后续影像学是一个新兴领域，专注于监测和评估治疗后肿瘤的反应。它受益于影像技术和患者管理系统的创新，使后续过程更加流畅和有效。对整体患者护理和影像准确性的日益重视支撑了后续影像学领域的增长潜力。 ### 按最终用户：医院和诊所（最大）与诊断影像中心（增长最快） 在自动化乳腺超声系统市场中，终端用户之间的市场份额分布显示，医院和诊所占据了最大的份额，在这些系统的整体采用中发挥了关键作用。该细分市场受益于先进技术与日常医疗实践的整合，这已成为提升患者护理和早期乳腺癌检测的必要条件。相反，诊断影像中心正成为增长最快的细分市场，反映出向满足多样化患者需求和偏好的专业影像服务的转变。 医院和诊所（主导）与诊断影像中心（新兴） 医院和诊所是自动乳腺超声系统市场的主要终端用户，因为它们能够投资于先进的诊断工具，从而改善患者的治疗效果。这些设施通常拥有采用最先进技术所需的资金和基础设施，使它们在乳腺影像服务的前沿。另一方面，诊断影像中心被视为一个新兴领域；它们专注于影像程序，并因其高效和以患者为中心的护理而日益受到认可。这些中心的兴起是由于对门诊服务的需求增加以及及时诊断的需要，导致它们在市场上迅速增长。 ### 按技术：常规超声（最大）与剪切波弹性成像（增长最快） 在自动化乳腺超声系统市场中，常规超声占据了最大的市场份额，因其在医学诊断中的广泛应用和成熟的存在而受到认可。由于其可靠性和成本效益，它成为许多医疗服务提供者的主要技术。剪切波弹性成像虽然较新，但因其能够提供组织硬度的定量测量而迅速获得关注，成为常规方法的有希望的替代方案，并有助于提高诊断准确性。 技术：常规超声（主导）与剪切波弹性成像（新兴） 传统超声波长期以来一直是自动乳腺超声系统市场的主导力量，因其在可视化乳腺组织方面的简单性和有效性而受到从业者的广泛青睐。其全面的成像能力使其成为乳腺癌筛查和诊断的基石。相比之下，剪切波弹性成像作为一种新兴技术，通过其创新的组织弹性评估方法，正在改变乳腺评估。这种技术不仅有助于区分良性和恶性病变，而且越来越多地融入常规筛查协议，反映出向更复杂的诊断方法的转变。 ## Regional Market Share Analysis ### 北美：引领创新与采用 北美是自动乳腺超声系统最大的市场，约占全球市场份额的45%。该地区的增长受到乳腺癌意识提高、技术进步和政府支持性法规的推动。FDA对创新设备的批准进一步催化了市场扩张，导致对早期检测解决方案的需求激增。美国是该市场的主要贡献者，GE医疗和霍洛吉克等关键参与者进行了大量投资。加拿大也发挥着重要作用，专注于改善医疗基础设施。竞争格局由一系列成熟公司和新兴初创企业组成，所有公司都在努力创新和改善患者结果。主要参与者的存在确保了强大的供应链和持续的技术进步。 ### 欧洲：监管支持与增长 欧洲是自动乳腺超声系统的第二大市场，约占全球市场份额的30%。该地区受益于严格的法规和指南，促进了先进医疗技术的采用。欧洲药品管理局（EMA）在确保创新解决方案符合安全和有效性标准方面发挥了重要作用，从而增强了消费者信心和市场增长。该地区的主要国家包括德国、法国和英国，这些国家的医疗系统正日益整合自动超声技术。西门子医疗和飞利浦医疗等主要参与者积极参与研发，提升其产品供应。竞争格局强劲，制造商与医疗提供者之间的合作重点在于提高诊断准确性和患者护理。 ### 亚太地区：快速增长与采用 亚太地区的自动乳腺超声系统市场正在迅速增长，约占全球市场份额的20%。乳腺癌的日益普遍和医疗支出的增加是推动这一增长的关键因素。中国和印度等国正在大力投资医疗基础设施，这预计将进一步推动对先进诊断工具的需求。监管机构也变得更加支持，促进了创新技术的快速批准。中国是该地区最大的市场，当地制造商如迈瑞做出了重要贡献。日本和韩国也是值得注意的参与者，专注于技术进步和质量提升。竞争格局正在演变，国内和国际公司都在争夺市场份额，导致创新和合作的动态环境。 ### 中东和非洲：具有潜力的新兴市场 中东和非洲地区在自动乳腺超声系统市场中逐渐崭露头角，约占全球市场份额的5%。增长主要受到乳腺癌意识提高和对先进诊断解决方案需求的推动。阿联酋和南非等国的政府正在投资医疗基础设施，这预计将增强自动超声技术的采用。该地区的主要参与者包括当地分销商和希望扩大市场份额的国际公司。竞争格局由一系列成熟公司和新进入者组成，所有公司都旨在满足对有效乳腺癌筛查解决方案日益增长的需求。政府与私营部门之间的合作努力对于促进创新和改善医疗服务的可及性至关重要。 .webp ## Competitive Benchmarking 自动化乳腺超声系统市场目前的特点是动态的竞争格局，受到技术进步和对早期乳腺癌检测日益重视的推动。GE医疗（美国）、西门子医疗（德国）和霍洛吉克（美国）等主要参与者处于前沿，各自采取不同的策略来增强市场存在感。GE医疗（美国）专注于通过开发先进的成像技术来推动创新，而西门子医疗（德国）则强调与医疗服务提供者的合作以扩大其影响力。霍洛吉克（美国）通过对研究和开发的承诺，战略性地定位自己，旨在推出满足不断变化的临床需求的尖端解决方案。这些策略共同促成了一个日益以技术差异化和协作增长为中心的竞争环境。 在商业策略方面，各公司越来越多地本地化制造和优化供应链，以提高运营效率。市场结构似乎适度分散，多个参与者争夺市场份额。这种分散性表明了一个创新和战略合作在塑造竞争动态中发挥关键作用的格局。这些主要参与者的集体影响力促进了一个竞争氛围，鼓励持续改进和适应市场需求。 2025年8月，西门子医疗（德国）宣布与一家领先的医疗服务提供者建立战略合作伙伴关系，以增强人工智能在乳腺成像中的整合。这一合作旨在利用人工智能算法提高诊断准确性并简化工作流程，从而满足对高效乳腺癌筛查解决方案日益增长的需求。这一合作伙伴关系的战略重要性在于其有潜力为诊断实践设定新标准，使西门子医疗成为乳腺超声系统中先进技术整合的领导者。 2025年9月，霍洛吉克（美国）推出了一种新的自动化乳腺超声系统，结合了机器学习能力以增强图像分析。这一发布具有重要意义，因为它反映了霍洛吉克对创新的承诺以及其通过先进技术改善患者结果的关注。通过整合机器学习，霍洛吉克旨在为医疗专业人员提供更准确诊断的工具，从而巩固其在市场中的竞争优势。 2025年10月，GE医疗（美国）推出了一项新举措，旨在扩大其在新兴市场的自动化乳腺超声产品。这一举措旨在应对在医疗资源有限的地区对可及乳腺癌筛查解决方案日益增长的需求。这一举措的战略重要性在于GE医疗能够进入新市场，同时为全球健康倡议做出贡献，从而提升其品牌声誉和市场存在感。 截至2025年10月，自动化乳腺超声系统市场的当前竞争趋势受到数字化、可持续性和人工智能整合的强烈影响。战略联盟越来越多地塑造着市场格局，因为公司认识到合作在推动创新和增强产品供应中的价值。展望未来，竞争差异化可能会从传统的基于价格的竞争演变为关注技术创新、供应链的可靠性以及满足医疗服务提供者和患者多样化需求的能力。 .webp ## Recent News & Developments - **2025年第三季度：在2025年7月，GE HealthCare推出了其Invenia ABUS 3.0，具备增强的AI病灶检测和更快的扫描时间。** GE HealthCare推出了Invenia ABUS 3.0自动化乳腺超声系统，具有先进的AI病灶检测和改进的工作流程效率，旨在为乳腺组织致密的女性提供补充筛查。 - **2025年第二季度：在2025年6月，西门子医疗获得了其Acuson ABUS Elite系统的CE标志认证。** 西门子医疗为其Acuson ABUS Elite获得了CE标志认证，这是一种具有自动定位功能的3D体积成像系统，使其能够在欧洲市场进行商业推广。 .webp ## Report Scope | 2024年市场规模 | 3.458（十亿美元） | | --- | --- | | 2025年市场规模 | 3.675（十亿美元） | | 2035年市场规模 | 6.758（十亿美元） | | 复合年增长率（CAGR） | 6.28%（2024 - 2035） | | 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 | | 基准年 | 2024 | | 市场预测期 | 2025 - 2035 | | 历史数据 | 2019 - 2024 | | 市场预测单位 | 十亿美元 | | 关键公司简介 | 市场分析进行中 | | 覆盖的细分市场 | 市场细分分析进行中 | | 关键市场机会 | 人工智能的整合提高了自动乳腺超声系统市场的诊断准确性。 | | 关键市场动态 | 技术进步和监管变化推动自动乳腺超声系统市场的增长。 | | 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 | ## Frequently Asked Questions **Q: 到2035年，自动乳腺超声系统的市场估值预计是多少？** A: 预计到2035年，市场将达到约67.58亿美元。 **Q: 2024年自动乳腺超声系统的市场估值是多少？** A: 在2024年，市场估值为34.58亿美元。 **Q: 在2025年至2035年的预测期内，自动乳腺超声系统市场的预期CAGR是多少？** A: 在此期间，市场的预期CAGR为6.28%。 **Q: 在自动乳腺超声系统市场中，哪些公司被视为关键参与者？** A: 主要参与者包括GE医疗、西门子医疗、飞利浦医疗和霍洛吉等。 **Q: 到2035年，2D自动化乳腺超声系统的预计收入是多少？** A: 预计到2035年，2D自动乳腺超声系统的收入将达到约29亿美元。 **Q: 到2035年，预计乳腺癌筛查应用的收入将达到多少？** A: 到2035年，乳腺癌筛查应用预计将产生约30亿美元。 **Q: 到2035年，自动化乳腺超声系统市场中诊断影像中心的预期收入是多少？** A: 预计到2035年，诊断影像中心的收入将达到约20亿美元。 **Q: 到2035年，预计剪切波弹性成像技术的收入增长是多少？** A: 剪切波弹性成像技术预计到2035年将增长到约15亿美元。 **Q: 在自动化乳腺超声系统市场中，预计哪个细分市场将实现最高的收入增长？** A: 乳腺癌筛查领域预计到2035年将实现最高的收入增长，达到30亿美元。 **Q: 2024年乳腺癌随访影像的收入是多少？** A: 在2024年，乳腺癌随访影像应用的收入约为7.58亿美元。 --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/automated-breast-ultrasound-system-market-28877*